<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-ijms-21-07078">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zengin</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Genc</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Taslimi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kestane</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Guclu</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ogutlu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Karabay</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Gulçin</surname>
    <given-names>I.</given-names>
   </name>
  </person-group>
  <article-title>Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors—Their antidiabetic, anticholinergic and antibacterial potentials</article-title>
  <source>Bioorg. Chem.</source>
  <year>2018</year>
  <volume>81</volume>
  <fpage>119</fpage>
  <lpage>126</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.08.003</pub-id>
  <pub-id pub-id-type="pmid">30118983</pub-id>
 </element-citation>
</ref>
